Stay updated on AKST4290 with Aflibercept in nAMD Clinical Trial
Sign up to get notified when there's something new on the AKST4290 with Aflibercept in nAMD Clinical Trial page.

Latest updates to the AKST4290 with Aflibercept in nAMD Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe history shows a new revision entry (Revision: v3.3.3) and removal of the HHS Vulnerability Disclosure item. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check25 days agoNo Change Detected
- Check47 days agoChange DetectedThe Record History shows a new revision entry (v3.3.2) and a deleted revision entry (v3.2.0).SummaryDifference0.1%

- Check54 days agoChange DetectedRemoved the government funding lapse notice and operating-status information; this banner was an administrative message rather than core study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check68 days agoChange DetectedVersion 6 (submitted 2022-10-24) was added to the Record History, extending the list of revisions for this study. This update indicates ongoing documentation of changes to the study record.SummaryDifference0.1%

- Check97 days agoChange DetectedUpdate includes a critical operating status notice and a new software version (v3.2.0), indicating updated deployment; the old version tag (v3.1.0) was removed.SummaryDifference12%

- Check104 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.SummaryDifference0.3%

Stay in the know with updates to AKST4290 with Aflibercept in nAMD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AKST4290 with Aflibercept in nAMD Clinical Trial page.